Transcripts

Rafael Holdings (RFL) earnings call transcripts

Earnings call transcripts for Rafael Holdings, Inc., with a summary, the guidance given, and what analysts pressed on.

  • trial results, September 30, 2026

    Management emphasized supportive subgroup and survival evidence while acknowledging the nonsignificant primary endpoint and FDA review risk.

    Sep 30, 2026Mildly positive0.20